FDA Inspection 1028446 — Qilu Pharmaceutical Co., Ltd. (High Tech Zone Site)
The FDA completed an inspection of Qilu Pharmaceutical Co., Ltd. (High Tech Zone Site) on Sep 20, 2017 in Jinan. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Sep 20, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Jinan (China)